| Name | Value | 
|---|---|
| Revenues | 0.0K | 
| Cost of Revenue | 1,074.0K | 
| Gross Profit | -1,074.0K | 
| Operating Expense | 8,869.0K | 
| Operating I/L | -9,943.0K | 
| Other Income/Expense | 2,586.0K | 
| Interest Income | 0.0K | 
| Pretax | -7,357.0K | 
| Income Tax Expense | 8.0K | 
| Net Income/Loss | -7,365.0K | 
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company specializing in diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. The company's Alpha-DaRT technology is used in clinical trials for skin, oral, pancreatic, and breast cancers, as well as in preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.